首页> 美国卫生研究院文献>Journal of Korean Medical Science >The comparison between Behçets disease and spondyloarthritides: does Behçets disease belong to the spondyloarthropathy complex?
【2h】

The comparison between Behçets disease and spondyloarthritides: does Behçets disease belong to the spondyloarthropathy complex?

机译:白塞氏病和脊椎关节炎的比较:白塞氏病是否属于脊椎关节炎综合症?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study was to clarify whether Behcet's disease (BD) could be classified into the spondyloarthropathy (SpA) complex. It was undertaken on 58 patients with BD (BD group), 56 patients with SpA (SpA group), and 3 patients who concurrently satisfied the criteria for BD and SpA (BDSpA group). The clinical parameters and known susceptible HLA antigens were compared between BD group and SpA group. In addition, 3 patients in BDSpA group were reviewed. The prevalence of definitive sacroiliitis (SI) in BD group and SpA group was 46.4% and 5.2%, respectively. However, none had a definitive SI in healthy controls. Enthesitis was observed in 3.4% of BD group and in 50% of SpA group. The patterns of eye involvement were different between these two groups. HLA-B27 was negative in all 49 patients of BD group, whereas it was positive in 67.9% of SpA group. The prevalence of HLA-B51 was 51.7% in BD group, and that in SpA group was 21.4%. One patient in BDSpA group was considered to have concurrent BD and ankylosing spondylitis (AS). Another patient was closer to AS, and the third to BD. Conclusively, it seems that BD could not be classified into the SpA complex.
机译:这项研究是为了澄清是否可以将Behcet病(BD)归类为脊椎关节炎(SpA)复合体。对58例BD患者(BD组),56例SpA患者(SpA组)和3例同时满足BD和SpA标准的患者(BDSpA组)进行了这项研究。比较BD组和SpA组的临床参数和已知的易感HLA抗原。另外,对BDSpA组的3例患者进行了回顾。 BD组和SpA组的定形sa炎(SI)患病率分别为46.4%和5.2%。但是,在健康对照组中,没有人具有确定的SI。 BD组的3.4%和SpA组的50%观察到了脑炎。两组的眼睛受累方式不同。 BD组的所有49例患者中HLA-B27均为阴性,而SpA组的67.9%为HLA-B27阳性。 BD组HLA-B51患病率为51.7%,SpA组为21.4%。 BDSpA组中的一名患者被认为患有并发性BD和强直性脊柱炎(AS)。另一例患者更接近AS,第三例患者接近BD。结论是,似乎无法将BD归类为SpA复合体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号